Literature DB >> 7264975

The effect of intracerebroventricular injections of morphine on vasopressin release in the rat.

L A Aziz, M L Forsling, C J Woolf.   

Abstract

1. An investigation was carried out to determine the effect of intracerebroventricular (I.C.V.) micro-injections of morphine on vasopressin (AVP) release in the urethane-anaesthetized rat. 2. Plasma AVP levels at different time intervals, following I.C.V. injection of 10-150 microgram morphine, were measured by radioimmunoassay. The effect of I.C.V. micro-injections of morphine on urine outflow was also studied in a group of water-loaded rats. 3. The vasopressin response to I.C.V. micro-injections of morphine was both dose- and time-dependent. High dose of 50 and 150 microgram morphine produced short latency stimulation of AVP release, followed by a fall. The low dose of 10 microgram morphine produced only a long latency inhibition. The most consistent response of I.C.V. injection of morphine was an inhibition of release. 4. Both stimulatory and inhibitory effects of morphine on vasopressin release were naloxone reversible and stereospecific. 5. I.C.V. micro-injections of morphine produced a dose-dependent rise in mean arterial blood pressure of short latency. Naloxone (0.5 mg/kg) completely abolished the rise seen with 10 microgram morphine and diminished the rise with 50 microgram. 6. Doses of 10 and 50 microgram morphine injected I.C.V. produced an immediate antidiuresis in water-loaded rats under urethane anaesthesia. 7. The vasopressin response to I.C.V. micro-injections of morphine is independent of the effects on the cardiovascular system and may involve different opiate receptor populations. The results also suggest the possibility that opiate receptors with different affinities for morphine may be responsible for the stimulatory and inhibitory effects of morphine on vasopressin release.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264975      PMCID: PMC1275417          DOI: 10.1113/jphysiol.1981.sp013592

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  17 in total

1.  An enzymatic solid-phase method for trace iodination of proteins and peptides with 125-iodine.

Authors:  S L Karonen; P Mörsky; M Siren; U Seuderling
Journal:  Anal Biochem       Date:  1975-07       Impact factor: 3.365

2.  Hypothalamic enkephalin neurones may regulate the neurohypophysis.

Authors:  J Rossier; E Battenberg; Q Pittman; A Bayon; L Koda; R Miller; R Guillemin; F Bloom
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

3.  Proceedings: An antibody to vasopressin in man.

Authors:  G W Bisset; A J Black; P J Hilton; N F Jones; D Kanjanapothi; M C Montgomery
Journal:  J Physiol       Date:  1974-05       Impact factor: 5.182

4.  Antidiuretic effect of morphine and vasopressin in morphine tolerant and non-tolerant rats, differential effects on urine composition.

Authors:  F Huidobro; J Huidobro-Toro
Journal:  Eur J Pharmacol       Date:  1979-10-26       Impact factor: 4.432

5.  Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones.

Authors:  G Clarke; P Wood; L Merrick; D W Lincoln
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

6.  Effects of beta-endorphin, morphine and naloxone on arginine vasopressin secretion and the electroencephalogram.

Authors:  H M Firemark; R E Weitzman
Journal:  Neuroscience       Date:  1979       Impact factor: 3.590

7.  Central cardiovascular effects of enkephalins and C-fragment of lipotropin [proceedings].

Authors:  W Feldberg; E Wei
Journal:  J Physiol       Date:  1978-07       Impact factor: 5.182

8.  Central sites at which morphine acts when producing cardiovascular effects [proceedings].

Authors:  W Feldberg; E Wei
Journal:  J Physiol       Date:  1978-02       Impact factor: 5.182

9.  Release of vasopressin by enkephalin.

Authors:  G W Bisset; H S Chowdrey; W Feldberg
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

10.  Evidence for dopamine as an inhibitor of vasoprotein release in man.

Authors:  S L Lightman; M Forsling
Journal:  Clin Endocrinol (Oxf)       Date:  1980-01       Impact factor: 3.478

View more
  12 in total

1.  Naloxone excites oxytocin neurones in the supraoptic nucleus of lactating rats after chronic morphine treatment.

Authors:  R J Bicknell; G Leng; D W Lincoln; J A Russell
Journal:  J Physiol       Date:  1988-02       Impact factor: 5.182

2.  The effect of vasopressin on solute and water excretion during and after surgical operations.

Authors:  N R Fieldman; M L Forsling; L P Le Quesne
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

3.  Intravenous bumetanide attenuates the rise in plasma vasopressin concentrations during major surgical operations.

Authors:  L Kaufman; P M Bailey
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

4.  A randomized cross-over study of enalapril in congestive heart failure: haemodynamic and hormonal effects during rest and exercise.

Authors:  I P Mulligan; A G Fraser; V Tirlapur; M J Lewis; R G Newcombe; A H Henderson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Central effects of dopamine on vasopressin release in the normally hydrated and water-loaded rat.

Authors:  M L Forsling; H Williams
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

6.  Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.

Authors:  J Bayliss; R Canepa-Anson; M S Norell; P Poole-Wilson; G Sutton
Journal:  Br Heart J       Date:  1986-03

7.  The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.

Authors:  W Knepel; D K Meyer
Journal:  J Physiol       Date:  1983-08       Impact factor: 5.182

8.  Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.

Authors:  S Ishikawa; R W Schrier
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

9.  Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.

Authors:  J Bayliss; M S Norell; R Canepa-Anson; C Reid; P Poole-Wilson; G Sutton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

10.  The effect of isoprenaline on plasma concentrations of immunoreactive beta-endorphin and beta-lipotropin in the conscious rat.

Authors:  W Knepel; H Anhut; D Nutto; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.